LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
• Rothschild Redburn Starts Iron Mountain (IRM) at Buy
• JPMorgan Starts NexGen Energy Limited (NXG:AU) at Overweight